Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]

8737 reported adverse events

Drugs of this class: DEXTROMETHORPHAN DEXTROMETHORPHAN POLISTIREX GUAIFENESIN AND DEXTROMETHORPHAN DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE

These side effects are most commonly reported by patients taking drugs of the Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 1604
1 DRUG ABUSE 729
2 TOXICITY TO VARIOUS AGENTS 702
3 OVERDOSE 615
4 DIZZINESS 516
5 DIARRHOEA 513
6 ACCIDENTAL OVERDOSE 406
7 COUGH 360
8 COMPLETED SUICIDE 355
9 DEATH 351
See all common reactions for Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]

Drugs of the Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BREAST CONSERVING SURGERY 29 0.0566
1 POSTMORTEM BLOOD DRUG LEVEL INCREASED 19 0.0509
2 OSMOLAR GAP INCREASED 4 0.0396
3 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 10 0.0285
4 NECROSIS ISCHAEMIC 12 0.0260
5 PERITONEAL PERFORATION 4 0.0242
6 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 5 0.0193
7 PATIENT DISSATISFACTION WITH DEVICE 4 0.0159
8 EXPOSURE VIA INGESTION 38 0.0150
9 ANION GAP ABNORMAL 4 0.0149
See all enriched reactions for Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]